Product Information

ABSORICA LD 24 MG CAPSULE is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $42.1644 per EA under NDC 10631000531. Its NADAC has been published 123 times since Apr 17, 2024.

FDA first approved this application on Nov 5, 2019.

The High Outlier badge above means this manufacturer's average price in the isotretinoin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ABSORICA LD 24 MG CAPSULE

isotretinoin
$42.1644per EA
High Outlier

Strength

24 mg/1

NDC

10631000531

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ISOTRETINOIN

Approval Type

New Drug (NDA)

FDA Application

NDA211913

FDA Approved

11/5/2019

On Market Since

11/20/2019

Pharmacological Classes

Retinoid
Retinoids

Price Statistics

The NADAC for ABSORICA LD 24 MG CAPSULE has been published 123 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$42.1644 per EA
All-time high$42.2562 (Nov 13, 2024)
All-time low$41.4980 (Sep 17, 2025)
52-week high$42.1644
52-week low$41.4980
Median price$41.7722
Average price$41.7815
Largest weekly change+1.2% (Sep 18, 2024)
Weeks tracked123
Tracking sinceApr 17, 2024

Price History

1W

0.0%

1M

0.0%

3M

+0.7%

6M

+0.8%

1Y

+1.2%

3Y

N/A

5Y

N/A

All

+0.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the isotretinoin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of ABSORICA LD 24 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ABSORICA LD 24 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $42.1644 per EA (NDC 10631000531), effective Aug 19, 2026.

How has the price of ABSORICA LD 24 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for ABSORICA LD 24 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for ABSORICA LD 24 MG CAPSULE?

Since Apr 17, 2024, the NADAC for ABSORICA LD 24 MG CAPSULE has ranged from a low of $41.4980 (Sep 17, 2025) to a high of $42.2562 (Nov 13, 2024), with a median of $41.7722 per EA.

Are there cheaper alternatives to ABSORICA LD 24 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of ABSORICA LD 24 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ABSORICA LD 24 MG CAPSULE?

ABSORICA LD 24 MG CAPSULE (NDC 10631000531) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.